TGFB1 and breast cancer: Recently, it was reported that emodin can inhibit the production of TGF-β1 in BC cells and macrophages, attenuate TGF-β1- or macrophage-induced EMT in BC cells and cancer stem cell (CSC) formation, inhibit the migration and invasion of BC cells, and prevent postoperative lung metastatic recurrence of BC 130.